PMID- 37998456 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231127 IS - 2227-9032 (Print) IS - 2227-9032 (Electronic) IS - 2227-9032 (Linking) VI - 11 IP - 22 DP - 2023 Nov 15 TI - Statistical Insight into China's Indigenous Diagnosis-Related-Group System Evolution. LID - 10.3390/healthcare11222965 [doi] LID - 2965 AB - The use of Diagnosis-Related Groups (DRG) is a prevalent payment system employed to control hospitalization costs and improve medical efficiency. China has developed an indigenized DRG payment system including Single Disease Payment (SDP), DRGs, and Big Data Diagnosis-Intervention Packet (DIP). In this study, we took cholecystitis as an example, drawing on both primary and secondary data to verify the effectiveness of China's indigenized DRG system and to introduce the evolution of DRGs in China. Primary data were gathered from Qilu Hospital in 2019-2021. Secondary data were collected from published literature from 2004-2016. Only studies with both pre-SDP/DRG and post-SDP/DRG groups were included. Among the studies included, 92.9% (13/14) reported a significant reduction in hospitalization costs after the implementation of SDP while other studies identified length of stay (LOS) and age as the most significant influential factors in SDP. Furthermore, we elaborated the efficiency of DRGs using data from 2738 inpatients in Qilu hospital. Moreover, 60% (6/10) of the studies from the databases also showed the efficiency of DRGs in different regions. SDP is efficient in saving hospitalization costs, but its implementation is limited. DRGs have a broader scope of application, but their effectiveness remains to be validated. DIP is a brand new concept in China, and more data are needed to assess its efficiency. FAU - Ma, Wenlong AU - Ma W AD - Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, China. FAU - Qu, Jing AU - Qu J AD - Department of Medical Records, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, China. FAU - Han, Hui AU - Han H AD - Office of Hospital President, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, China. FAU - Jiang, Zixia AU - Jiang Z AD - Department of Medical Insurance, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, China. FAU - Chen, Tiantian AU - Chen T AD - Department of Medical Records, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, China. FAU - Lu, Xuefeng AU - Lu X AD - Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, China. FAU - Lu, Jiaoyang AU - Lu J AD - Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, China. AD - Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan 250012, China. LA - eng PT - Journal Article DEP - 20231115 PL - Switzerland TA - Healthcare (Basel) JT - Healthcare (Basel, Switzerland) JID - 101666525 PMC - PMC10671376 OTO - NOTNLM OT - China OT - cholecystitis OT - diagnosis intervention packet OT - diagnosis-related groups OT - evolution OT - payment COIS- The authors declare no conflict of interest. EDAT- 2023/11/24 12:43 MHDA- 2023/11/24 12:44 PMCR- 2023/11/15 CRDT- 2023/11/24 09:36 PHST- 2023/09/17 00:00 [received] PHST- 2023/11/09 00:00 [revised] PHST- 2023/11/12 00:00 [accepted] PHST- 2023/11/24 12:44 [medline] PHST- 2023/11/24 12:43 [pubmed] PHST- 2023/11/24 09:36 [entrez] PHST- 2023/11/15 00:00 [pmc-release] AID - healthcare11222965 [pii] AID - healthcare-11-02965 [pii] AID - 10.3390/healthcare11222965 [doi] PST - epublish SO - Healthcare (Basel). 2023 Nov 15;11(22):2965. doi: 10.3390/healthcare11222965.